JP2016529908A5 - - Google Patents

Download PDF

Info

Publication number
JP2016529908A5
JP2016529908A5 JP2016539674A JP2016539674A JP2016529908A5 JP 2016529908 A5 JP2016529908 A5 JP 2016529908A5 JP 2016539674 A JP2016539674 A JP 2016539674A JP 2016539674 A JP2016539674 A JP 2016539674A JP 2016529908 A5 JP2016529908 A5 JP 2016529908A5
Authority
JP
Japan
Prior art keywords
mvp
solution
molecule
binding
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016539674A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016529908A (ja
JP6549126B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/064352 external-priority patent/WO2015036917A2/en
Publication of JP2016529908A publication Critical patent/JP2016529908A/ja
Publication of JP2016529908A5 publication Critical patent/JP2016529908A5/ja
Application granted granted Critical
Publication of JP6549126B2 publication Critical patent/JP6549126B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016539674A 2013-09-10 2014-09-09 生成された溶液からのモックウイルス粒子の除去を定量するための方法およびキット Active JP6549126B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361875729P 2013-09-10 2013-09-10
US61/875,729 2013-09-10
PCT/IB2014/064352 WO2015036917A2 (en) 2013-09-10 2014-09-09 Methods and kits for quantifying the removal of mock virus particles from a purified solution

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019118216A Division JP2019195333A (ja) 2013-09-10 2019-06-26 生成された溶液からのモックウイルス粒子の除去を定量するための方法およびキット

Publications (3)

Publication Number Publication Date
JP2016529908A JP2016529908A (ja) 2016-09-29
JP2016529908A5 true JP2016529908A5 (enExample) 2017-11-16
JP6549126B2 JP6549126B2 (ja) 2019-07-31

Family

ID=52625972

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016539674A Active JP6549126B2 (ja) 2013-09-10 2014-09-09 生成された溶液からのモックウイルス粒子の除去を定量するための方法およびキット
JP2019118216A Withdrawn JP2019195333A (ja) 2013-09-10 2019-06-26 生成された溶液からのモックウイルス粒子の除去を定量するための方法およびキット

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019118216A Withdrawn JP2019195333A (ja) 2013-09-10 2019-06-26 生成された溶液からのモックウイルス粒子の除去を定量するための方法およびキット

Country Status (7)

Country Link
US (4) US9632087B2 (enExample)
EP (1) EP3044339B1 (enExample)
JP (2) JP6549126B2 (enExample)
CN (1) CN105899684B (enExample)
AU (3) AU2014320015B2 (enExample)
DK (1) DK3044339T3 (enExample)
WO (1) WO2015036917A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3044339T3 (da) * 2013-09-10 2019-08-12 MockV Solutions Fremgangsmåder og sæt til kvantificering af fjernelsen af falske (MOCK) viruspartikler fra en renset opløsning
WO2020100957A1 (ja) * 2018-11-14 2020-05-22 日産化学株式会社 生体材料の保存、前処理、分析のための容器及び方法
JP7390466B2 (ja) * 2020-02-28 2023-12-01 旭化成メディカル株式会社 ウイルスクリアランス性能の評価方法
US12203914B2 (en) 2020-11-12 2025-01-21 Sartorius Bioanalytical Instruments, Inc. Viral clearance evaluation for biological medical product preparation processes
CN118465260B (zh) * 2024-07-09 2024-10-15 浙江康佰裕生物科技有限公司 测定逆转录病毒包膜蛋白elisa方法的建立及应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01503675A (ja) * 1986-09-08 1989-12-14 アプライド・バイオテクノロジー・インコーポレーテツド 中空ウイルスキヤプシドのワクチン
US5173399A (en) * 1988-06-10 1992-12-22 Abbott Laboratories Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests
CA2002839C (en) * 1988-11-14 2000-10-10 Neal S. Young Parvovirus capsids
WO1993000103A1 (en) * 1991-06-21 1993-01-07 The Wistar Institute Of Anatomy And Biology Chimeric envelope proteins for viral targeting
US5814442A (en) * 1994-06-10 1998-09-29 Georgetown University Internally controlled virion nucleic acid amplification reaction for quantitation of virion and virion nucleic acid
US7122645B2 (en) 2000-03-27 2006-10-17 Smithkline Beecham Corporation Detection of viable agents
EP2365082A1 (en) * 2000-06-27 2011-09-14 Pfizer Animal Health S.A. BVDV virus-like particles
US20040002058A1 (en) * 2001-06-21 2004-01-01 Uab Research Foundation Chimeric capsid proteins and uses thereof
US7041444B2 (en) * 2003-01-14 2006-05-09 Washington University Murine calicivirus
WO2005023313A1 (en) * 2003-09-09 2005-03-17 Virxsys Corporation Lentivirus vector-based approaches for generating an immune response to hiv humans
EP1973608A1 (en) * 2005-12-14 2008-10-01 Cytos Biotechnology AG Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
US20100297604A1 (en) * 2006-06-09 2010-11-25 Xing-Xiang Li Methods and reagents for virus isolation and detection
WO2008036899A2 (en) * 2006-09-22 2008-03-27 Amgen Inc. Methods for removing viral contaminants during protein purification
JP5710254B2 (ja) * 2007-09-14 2015-04-30 アンスティテュ・パストゥールInstitut Pasteur 外来エピトープを含む組換え偽ウイルスの発現および分泌を可能とするポリヌクレオチド、それらの製造および使用
GB0803068D0 (en) * 2008-02-20 2008-03-26 Health Prot Agency Cross-linked biological indicator
NZ592097A (en) * 2008-10-20 2013-01-25 Abbott Lab Viral inactivation during purification of il-12 and il-18 antibodies
US9744228B2 (en) * 2010-04-07 2017-08-29 Norvartis Ag Method for generating a parvovirus B19 virus-like particle
BR112012026095A2 (pt) * 2010-04-14 2015-09-15 Emd Millipore Corp métodos de produção de estoques de vírus de alta pureza e altos títulos e métodos de uso dos mesmos.
DK3044339T3 (da) * 2013-09-10 2019-08-12 MockV Solutions Fremgangsmåder og sæt til kvantificering af fjernelsen af falske (MOCK) viruspartikler fra en renset opløsning

Similar Documents

Publication Publication Date Title
JP7210518B2 (ja) 組み換えバクテリオファージを使用する、微生物の迅速検出のための方法及びシステム
Guthmiller et al. An efficient method to generate monoclonal antibodies from human B cells
Maramorosch et al. Methods in Virology: Volume V
Anzenbacher et al. Metabolism of drugs and other xenobiotics
Castello et al. Comprehensive identification of RNA-binding proteins by RNA interactome capture
JP2016529908A5 (enExample)
US10519483B2 (en) Methods and systems for rapid detection of microorganisms using infectious agents
CN103890176A (zh) 制备生物材料的方法
KR20170138462A (ko) 바이러스에 대한 무균 정제 방법
CN103764827A (zh) 可用于分离和/或纯化核酸的试剂
Lerer et al. Highly efficient purification of recombinant VSV-∆ G-spike vaccine against SARS-CoV-2 by flow-through chromatography
JP2019195333A (ja) 生成された溶液からのモックウイルス粒子の除去を定量するための方法およびキット
WO2011103163A2 (en) Nucleic acid extraction from complex matrices
TW201632621A (zh) 篩選具抗原專一性之融合瘤細胞之方法
CA2967008A1 (en) Chaotrope- and volatile-free method for purifying nucleic acids from plasma
US20210246160A1 (en) Biomolecule isolation and inhibitor removal
Sousa et al. A novel method for human hematopoietic stem/progenitor cell isolation from umbilical cord blood based on immunoaffinity aqueous two-phase partitioning
JP2014523405A5 (enExample)
Keck et al. Comparison of biosafety and diagnostic utility of biosample collection cards
Gasch et al. Whole genome amplification in genomic analysis of single circulating tumor cells
Wendlandt et al. Getting hold of the tobamovirus particle—Why and how? Purification routes over time and a new customizable approach
CN105802973B (zh) 一种靶向髓系分化抗原cd33蛋白的核酸适配体及应用
Luitjens et al. Production and purification of recombinant proteins
Mardini et al. Hidden pitfalls of using onion pollen in molecular research
Ding et al. Chromatin immunoprecipitation assay of brain tissues using Percoll gradient-purified nuclei